Pharmaceutical

Generics expected to improve access for patients with idiopathic pulmonary fibrosis

The idiopathic pulmonary fibrosis (IPF) market is underserved with just two licensed pharmaceutical treatments approved by the FDA in 2014.

Sep 27, 2023 - 20:00
Generics expected to improve access for patients with idiopathic pulmonary fibrosis
The idiopathic pulmonary fibrosis (IPF) market is underserved with just two licensed pharmaceutical treatments approved by the FDA in 2014.
Read the original article

Tags:

Previous Article

Novo Nordisk and Evotec launch translational drug discovery accelerator

Next Article

Mobile health strategies: Should you build or partner for success?

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

From rapid cooling body bags to ‘prescriptions’ for AC, doctors prepare for a future of extreme heat

From rapid cooling body bags to ‘prescriptions’ for AC,...

Jul 18, 2023

Europe recommends the approval of Pfizer’s RSV vaccine for older adults and in pregnancy

Europe recommends the approval of Pfizer’s RSV vaccine ...

Jul 22, 2023

STAT+: Cerebral and other telehealth startups face new legal and regulatory challenges over ad models

STAT+: Cerebral and other telehealth startups face new ...

Mar 22, 2023